Background: Delayed cerebral ischemia (DCI) is a common and serious complication of
aneurysmal subarachnoid hemorrhage (aSAH). Though many clinical trials have looked at …

Platelets are active key players in haemostasis. Qualitative platelet dysfunctions result in
thrombocytopathies variously characterized by defects of their adhesive and procoagulant …

This study aimed to establish a new scoring model based on the early brain injury (EBI)
indicators to predict the 90-day functional outcomes in patients with aneurysmal …

Aneurysmal subarachnoid hemorrhage (aSAH) patients develop delayed cerebral ischemia
and delayed deficits (DCI) within 2 weeks of aneurysm rupture at a rate of approximately …

During the past decades, it has been increasingly recognized that the major function of
accelerating membrane-dependent reactions of blood coagulation is predominantly …

Aneurysmal subarachnoid hemorrhage (SAH) remains a devastating cerebrovascular
disease [1] and should be treated as a systemic disorder needing intensive care, not merely …

Purpose Post-hemorrhage period after aneurysmal subarachnoid hemorrhage (aSAH) has
several systemic manifestations including prothrombotic and pro-inflammatory states. Inter …

Accurately predicting clinical outcome of aneurysmal subarachnoid hemorrhage (aSAH)
patients is difficult. The purpose of this study was to develop and test a new fully-automated …

Microthrombosis after aneurysmal subarachnoid hemorrhage (aSAH) is considered to
initiate neuroinflammation, vessel remodeling, and blood-brain barrier leakage. We aimed to …

Background The ability to achieve hemostasis after spontaneous subarachnoid hemorrhage
(SAH) plays a pivotal role in outcome. Changes in coagulation in the early hours after SAH …